Anti SLC9A3R1 pAb (ATL-HPA027247 w/enhanced validation)
Atlas Antibodies
- Catalog No.:
- ATL-HPA027247-25
- Shipping:
- Calculated at Checkout
$395.00
Gene Name: SLC9A3R1
Alternative Gene Name: EBP50, NHERF
Isotype: IgG
Interspecies mouse/rat: ENSMUSG00000020733: 86%, ENSRNOG00000003232: 88%
Entrez Gene ID: 9368
Uniprot ID: O14745
Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.
Storage Temperature: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
Product Specifications | |
Application | WB, ICC, IHC |
Reactivity | Human |
Clonality | Polyclonal |
Host | Rabbit |
Immunogen | GGDETKLLVVDRETDEFFKKCRVIPSQEHLNGPLPVPFTNGEIQKENSREALAEAALESPRPALVRSASSDTSEELNSQDSPPKQDSTAPSSTSSSDPILDFNISLAMAKERAHQKRSSKRAPQMDWSKKNELFSNL |
Gene Sequence | GGDETKLLVVDRETDEFFKKCRVIPSQEHLNGPLPVPFTNGEIQKENSREALAEAALESPRPALVRSASSDTSEELNSQDSPPKQDSTAPSSTSSSDPILDFNISLAMAKERAHQKRSSKRAPQMDWSKKNELFSNL |
Gene ID - Mouse | ENSMUSG00000020733 |
Gene ID - Rat | ENSRNOG00000003232 |
Buffer | 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative. |
Documents & Links for Anti SLC9A3R1 pAb (ATL-HPA027247 w/enhanced validation) | |
Datasheet | Anti SLC9A3R1 pAb (ATL-HPA027247 w/enhanced validation) Datasheet (External Link) |
Vendor Page | Anti SLC9A3R1 pAb (ATL-HPA027247 w/enhanced validation) at Atlas Antibodies |
Documents & Links for Anti SLC9A3R1 pAb (ATL-HPA027247 w/enhanced validation) | |
Datasheet | Anti SLC9A3R1 pAb (ATL-HPA027247 w/enhanced validation) Datasheet (External Link) |
Vendor Page | Anti SLC9A3R1 pAb (ATL-HPA027247 w/enhanced validation) |
Citations for Anti SLC9A3R1 pAb (ATL-HPA027247 w/enhanced validation) – 1 Found |
Patten, Darren K; Corleone, Giacomo; Győrffy, Balázs; Perone, Ylenia; Slaven, Neil; Barozzi, Iros; Erdős, Edina; Saiakhova, Alina; Goddard, Kate; Vingiani, Andrea; Shousha, Sami; Pongor, Lőrinc Sándor; Hadjiminas, Dimitri J; Schiavon, Gaia; Barry, Peter; Palmieri, Carlo; Coombes, Raul C; Scacheri, Peter; Pruneri, Giancarlo; Magnani, Luca. Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer. Nature Medicine. 2018;24(9):1469-1480. PubMed |